Finally, as for Progression-Free Interval (PFI) (Fig. 6D), LINC-PINT exhibited a beneficial effect (HR < 1, P < 0.05) in Mesothelioma (MESO), PAAD, and SKCM, thus offering potential therapeutic implications in these malignancies. The gene discussed is LINC-PINT; the disease is mesothelioma.